DPYSL5 and lung cancer: The cancer association typically varies according to the autoantibody, e.g., Ri-Abs with breast and lung cancer [81], Ma2-Abs with testicular or lung cancer [82, 83], CV2/CRMP5- [84, 85] and Hu-Abs with small cell lung cancer [30].